arrow
P

Peter Hall

University of Edinburgh
H指数:50
被引数:9,972

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Does earlier diagnosis and treatment of brain tumours matter? Time-to-treatment intervals and tumour size at detection; impact on survival and other patient outcomes

脑肿瘤的早期诊断和治疗是否重要?治疗时间间隔和检测时肿瘤大小对生存率及其他患者结局的影响

2026-09-280
OA
Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across Europe
2026-01-220
OAAI
Morphine for chronic breathlessness (MABEL) in the UK: a health economic evaluation of a multisite, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial

英国的吗啡治疗慢性呼吸困难 (MABEL): 对多站点,平行组,剂量滴定,双盲,随机,安慰剂对照试验的健康经济学评估

2025-11-050
OA
Anaemia management with red blood cell transfusion to improve post-intensive care disability: Protocol for the ABC post-ICU randomised controlled trial

贫血管理联合红细胞输注以改善重症监护后残疾:ABC重症监护后随机对照试验方案

2025-11-010
PRE
Multidisciplinary Prehabilitation Reduces Hospitalization Time and Suggests Improved Survival in Patients with Radiologically Diagnosed Lung Cancer

多学科预康复可缩短放射学诊断肺癌患者的住院时间,并提示其生存率得到改善。

2025-10-160
OAAI
Morphine for chronic breathlessness (MABEL) in the UK: a multi-site, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial

英国慢性呼吸困难 Morphine 治疗(MABEL)研究:一项多中心、平行组、剂量滴定、双盲、随机、安慰剂对照试验

2025-09-280
OAAI
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer
2025-02-130
OA
Attrition between lines of therapy and real-world outcomes of patients with HER2-positive metastatic breast cancer in Europe: a cohort study leveraging electronic medical records
2024-10-200
OAAI
Decentralized Colorectal Cancer Care: Benefit or Burden in the Pandemic? - An International Comparative Study in two Health Care Systems (DCCC Study)
2024-05-160
OA